echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Microbiology News > The Application of Bacterial Luciferase as a Reporter Gene in Mycobacteria

    The Application of Bacterial Luciferase as a Reporter Gene in Mycobacteria

    • Last Update: 2021-02-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Bioluminescence is the product of two distinct enzymes, firefly luciferase and bacterial luciferase. The application of the firefly enzyme in the study of mycobacteria has been described by other groups (
    1
    ,
    2
    ) (
    see
    Chapter 31 ). The bacterial-luciferase enzyme is a drmer of approx 80 kDa, consisting of an α- and β-subunit (
    3
    ,
    4
    ). It catalyzes the oxidation of long-chain fatty acids (>7 carbons) and reduced riboflavin, generating blue-green light (λ = 490 nm) in the process. The reaction can be written as follows: FMNH
    2
    + RCHO + O
    2
    → FMN + H
    2
    O + RCOOH + Light
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.